Table 1A. Association of RFPL3 and CBP expression with patient's clinicopathological features in lung ADC.

	Total (n = 56)	RFPL3 and CBP low expression (n = 33)	RFPL3 and CBP high expression (n = 23)	p
Gender
Male	27	17 (63%)	10 (37%)	0.554
Female	29	16 (55%)	13 (45%)
Age,y
<60	26	15	11	0.861
≥60	30	18	12
pT factor
T1+ T2	46	29	17	0.179
T3	10	4	6
pN factor
N0	39	26	13	0.075
N1+N2	17	7	10

Abbreviations: ADC, adenocarcinoma